Interesting T2DM: Weight Loss Device & Meds Update

Slideshow

Our October list of news and research includes FDA approval of a new weight loss device, a comparison of canagliflozin & glimepiride, and more.

We present a selection of interesting news and research for the month of October focusing on type 2 diabetes. See the slide legends for links to the article summaries.Be on the lookout for our regular Interesting Endocrinology series later this month, which will cover type 1 diabetes and other endocrine disorders. 

Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
© 2024 MJH Life Sciences

All rights reserved.